Literature DB >> 19105218

Duration effect of obsessive-compulsive disorder on cognitive function: a functional MRI study.

Tomohiro Nakao1, Akiko Nakagawa, Takashi Yoshiura, Eriko Nakatani, Maiko Nabeyama, Hirokuni Sanematsu, Osamu Togao, Kazuko Yoshioka, Mayumi Tomita, Toshihide Kuroki, Shigenobu Kanba.   

Abstract

BACKGROUND: The inconsistency of previous reports examining cognitive function in obsessive-compulsive disorder (OCD) suggests its heterogeneity. In this study, we examined the effect of illness duration on cognitive function in OCD.
METHODS: We examined the cognitive function of 32 OCD patients and 16 healthy volunteers by neuropsychological tests and functional magnetic resonance imaging while they performed the Stroop and N-back tasks to assess attention and nonverbal memory. The patients were divided into two groups by illness duration: a short-term group (n=17, 5.5+/-3.1 years) and a long-term group (n=15, 20.3+/-6.1 years). Statistical analysis was performed to determine the differences between these two groups and the normal control group (n=16).
RESULTS: The long-term group showed attention deficit and nonverbal memory dysfunction on the neuropsychological tests. In contrast, on functional magnetic resonance imaging, the short-term group showed weaker activation of the right caudate during the Stroop task and stronger activation of the right dorso-lateral prefrontal cortex during the N-back task than the long-term and normal control groups.
CONCLUSIONS: The results suggested that abnormal brain activation occurs in the early phase of OCD and that the long-term persistence of OCD might involve a decline in cognitive function.

Entities:  

Mesh:

Year:  2009        PMID: 19105218     DOI: 10.1002/da.20484

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  8 in total

1.  Effects of gender and executive function on visuospatial working memory in adult obsessive-compulsive disorder.

Authors:  Riccardo Maria Martoni; Giulia Salgari; Elisa Galimberti; Maria Cristina Cavallini; Joseph O'Neill
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-14       Impact factor: 5.270

2.  Cognitive and Experienced Flexibility in Patients With Anorexia Nervosa and Obsessive Compulsive Disorder.

Authors:  Lot Catharina Sternheim; Boris van Passel; Alexandra Dingemans; Danielle Cath; Unna Nora Danner
Journal:  Front Psychiatry       Date:  2022-05-09       Impact factor: 5.435

3.  Obsessive-compulsive disorder is associated with broad impairments in executive function: A meta-analysis.

Authors:  Hannah R Snyder; Roselinde H Kaiser; Stacie L Warren; Wendy Heller
Journal:  Clin Psychol Sci       Date:  2015-03

4.  Cognitive performance in children and adolescents at high-risk for obsessive-compulsive disorder.

Authors:  Elisa Teixeira Bernardes; Leonardo Cardoso Saraiva; Marina de Marco E Souza; Marcelo Queiroz Hoexter; Priscila Chacon; Guaraci Requena; Euripedes Constantino Miguel; Roseli Gedanke Shavitt; Guilherme Vanoni Polanczyk; Carolina Cappi; Marcelo Camargo Batistuzzo
Journal:  BMC Psychiatry       Date:  2020-07-20       Impact factor: 3.630

5.  Brain microstructural changes and cognitive correlates in patients with pure obsessive compulsive disorder.

Authors:  Gianfranco Spalletta; Fabrizio Piras; Sabrina Fagioli; Carlo Caltagirone; Federica Piras
Journal:  Brain Behav       Date:  2014-01-27       Impact factor: 2.708

Review 6.  Real-time functional magnetic resonance imaging in obsessive-compulsive disorder.

Authors:  Óscar F Gonçalves; Marcelo C Batistuzzo; João R Sato
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-12       Impact factor: 2.570

Review 7.  A Clinical Staging Model for Obsessive-Compulsive Disorder: Is It Ready for Prime Time?

Authors:  Leonardo F Fontenelle; Murat Yücel
Journal:  EClinicalMedicine       Date:  2019-02-12

Review 8.  Response inhibition and interference control in obsessive-compulsive spectrum disorders.

Authors:  Laura S van Velzen; Chris Vriend; Stella J de Wit; Odile A van den Heuvel
Journal:  Front Hum Neurosci       Date:  2014-06-11       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.